SCHEMBL6749977

SCHEMBL6749977

NNC(=O)Cc1ccc(N2C(=O)C=CC2=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AOC2 O75106 3/20 0.59
▸ MGLL Q99685 11/20 0.55
▸ FAAH O00519 5/20 0.55
▸ NPSR1 Q6W5P4 3/20 0.49
▸ PKM P14618 2/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ XBP1 P17861 1/20 0.49
▸ CCR6 P51684 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ DDAH1 O94760 1/20 0.47
▸ HSP90AA1 P07900 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ AOC3 Q16853 3/20 0.44
▸ CACNA1B Q00975 1/20 0.43
▸ APBA1 Q02410 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625817 0.81 MGLL (0.49) AOC2MGLLFAAHNPSR1PKM
SCHEMBL44044 0.81 MGLL (0.54) AOC2MGLLFAAHNPSR1PKM
SCHEMBL24452258 0.81 MGLL (0.60) MGLLFAAHNPSR1PKMMAPK1
SCHEMBL28390770 0.80 MGLL (0.56) AOC2MGLLFAAHNPSR1PKM
Hydrochloric Acid SCHEMBL44524 0.80 MGLL (0.52) AOC2MGLLFAAHNPSR1PKM
Hydrochloric Acid SCHEMBL443354 0.80 MGLL (0.52) AOC2MGLLFAAHNPSR1PKM
SCHEMBL13410068 0.80 MGLL (0.60) AOC2MGLLFAAHAOC3
SCHEMBL11796135 0.80 AOC2 (0.66) AOC2HPGDHTTAOC3
Hydrazine SCHEMBL16908509 0.79 MGLL (0.58) MGLLFAAHNPSR1PKMMAPK1
SCHEMBL6755043 0.79 MGLL (0.62) MGLLFAAHNPSR1PKMMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECHNOLOG (CN) 2023-05-25 — — US disclosed
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECHNOLOG (CN) 2023-05-25 — — US disclosed
US-6709679-B2 CONSISTING OF NATIVE OR THIOLATED TRANSFERRIN OR ALBUMIN OR OF POLYETHYLENE GLYCOL WITH ATLEAST ONE MERCAPTAN, HYDROXY OR AMINE GROUP AND CYTOSTATIC COMPOUNDS DERIVED THROUGH MALEINIMIDE OR HYDROXYSUCCINIMIDE ESTER COMPOUNDS KRATZ FELIX (DE) 2004-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof CD47, FCGR2A, CD40 AOC2 3524/4885MGLL 2474/4885FAAH 2216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback